BACKGROUND
The pituitary is a rare site for metastatic spread. Pituitary metastases (PMs) account for about 1% of lesions removed by pituitary surgery. Data on epidemiology, symptoms, pituitary hormone assessment, and radiological findings are limited. This paper aimed to describe our retrospective cohort of histologic...
L. Demarchis, S. Chiloiro, A. Giampietro et al.· Endocrine Oncology· 0 citations
Glioblastoma, IDH-wildtype (GBM) is the most common and aggressive primary brain tumor in adults, with a median overall survival of 15–18 months. New therapeutic targets are needed to improve patients’ prognosis. Due to their powerful regulatory capabilities, miRNAs could be possible candidate targets. MiR-126 is consi...
G. Castellani, M. Buccarelli, A. Affinito et al.· Molecular Therapy: Nucleic A...· 0 citations
Objectives: Our objective was to systematically evaluate the role of intraoperative neurophysiological monitoring (IONM) in supratentorial meningioma surgery, focusing on intraoperative changes, surgical decision-making, and postoperative neurological outcomes. Methods: A PRISMA-guided systematic review was conducted a...
Martina Offi, Renata Martinelli, Benedetta Burattini et al.· Diagnostics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
